Advanced, HER2 Negative Breast Cancer Treatment
Different breast cancers behave in different ways, which necessitates separate treatment guidelines to address the individual characteristics of specific types of cancer. As knowledge evolves, treatment guidelines are updated to reflect up-to-date information about breast cancer. Recently, the American Society of Clinical Oncology (ASCO) published guidelines on the use of chemotherapy and targeted therapy in the treatment of patients with advanced, HER2 negative breast cancer.
What is HER2 Negative Breast Cancer?
HER2, or human epidermal growth factor receptor 2, is a protein that the human body develops to help regulate reproduction of the cells. Sometimes the gene responsible for developing this protein will over-replicate itself, which can result in overproduction of HER2. […]